Coronavirus company news summary – AstraZeneca wins antibody product contract – US Army readies for Covid-19 second wave response

6 October 2020 (Last Updated October 6th, 2020 10:52)

6 October

The US Army Contracting Command in Aberdeen Proving Ground, Maryland has awarded AstraZeneca a firm-fixed-price contract to produce AZD7442, a combination antibody product. AZD7442 is intended to prevent or treat clinical effects of SARS-CoV-2. Under the contract, the company will manufacture a minimum of 100,000 treatment courses. Work on the contract will be carried out in Gaithersburg, Maryland. It has an estimated completion date of 30 June next year.

US Army Garrison Wiesbaden has conducted a tabletop exercise to prepare to respond to a second Covid-19 wave. Around 100 participants from the garrison, US Army Europe, 66th Military Intelligence Brigade, the Army Corps of Engineers, Army and Air Force Exchange Service, Commissary, Red Cross, USO, Department of Defense Education Activities and other units and partners took part in the exercise virtually. The exercise also involved discussions on scenarios and contingencies to better respond to a second heavy wave of virus or issues associated with seasonal flu.

Members of the New York National Guard have shared the virus mitigating lessons they have learned with the Brazilian military. New York was one of the first epicentres in the US. The state established five joint task forces across New York to manage personnel, logistics and medical assets. The discussions also covered the use of field hospitals and other alternate care facilities. According to the US Army, there were more than 32,000 Covid-19 deaths in New York and more than 145,000 in Brazil.